Sound Familiar ?If it does, then it's how Paladin was built by the Goodmans and sold for total consideration of $3 billion.
Paladin was formed in 1995, with just a single drug and a market cap of $1 million.
4 years later and sales had advanced to $10 million and the market cap to $85 million.
Acquire and merge was goodie's favourite move .....PDP and ?
From an earlier research report..
Paladin Labs (PLB) is a specialty pharmaceutical company focused
on acquiring, in-licensing, marketing and distributing pharmaceutical products primarily for Canadian markets.
Its core focus is on smaller, niche markets and products which are unlikely to compete with larger pharmaceutical companies (pharmas). These markets include specialty therapeutic elds and other geographic markets (excluding the US and Europe).
In the Canadian pharmaceutical space, PLB has carved a niche market for itself with its focus on specialty therapeutic elds and the development of synergistic relations with other pharmas.
PLB cultivates long-term relationships with the larger pharmas by sourcing and distrib- uting under-promoted or mature drugs produced by the large pharmas whose revenue potential are not signi cant enough.
To smaller pharmas, where marketing can incur excessive expense and requires expertise, Paladin positions itself as a marketing and distributing partner in ex-